STC
AEGR

SEI Trust Company’s Aegerion Pharmaceuticals AEGR Stock Holding History

SEI Trust Company’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$337K Buy
+10,100
New +$313K ﹤0.01% 1202
2014
Q2 		– Sell
-949
Closed -$35.3K – 1701
2014
Q1 		$44K Buy
949
+172
+22% +$10.1K ﹤0.01% 1562
2013
Q4 		$55K Buy
+777
New +$59.4K ﹤0.01% 1578
2013
Q3 		– Sell
-4,250
Closed -$269K – 1622
2013
Q2 		$269K Buy
+4,250
New +$226K ﹤0.01% 1070

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SEI Trust Company's AEGR Position: Q3 2014 in Review

SEI Trust Company opened a new position in Aegerion Pharmaceuticals (AEGR) in Q3 2014: 10,100 shares worth $337K. The stake represents ﹤0.01% of the portfolio and ranks #1202 among its holdings. This is a return to the name: SEI Trust Company previously reported a position in AEGR as recently as Q1 2014.

SEI Trust Company first reported a position in AEGR in Q2 2013 and has held it in 4 quarters since. 131 funds tracked by Wall St. Rank hold AEGR as of Q3 2014.

  • SEI Trust Company held 10,100 shares of Aegerion Pharmaceuticals worth $337K as of Q3 2014.
  • Aegerion Pharmaceuticals was a new SEI Trust Company position in Q3 2014.
  • Aegerion Pharmaceuticals made up ﹤0.01% of SEI Trust Company's portfolio in Q3 2014, its #1202 holding.
  • SEI Trust Company first reported a position in Aegerion Pharmaceuticals in Q2 2013 and has held it in 4 quarters since.
  • 131 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.